Alan Auerbach Puma Biotechnology CEO Rating

Puma Biotechnology CEO Alan Auerbach Bio

Mr. Alan H. Auerbach is the Founder of Puma Biotechnology, Inc. and has been its Executive Chairman, Chief Executive Officer and President since October 4, 2011 and serves as its Secretary. Mr. Auerbach is a Private Equity Partner at Burrill Private Equity. He serves as an Advisor at Los Angeles Syndicate of Technology, Inc. He founded Cougar Biotechnology, Inc. in May 2003 and served as its Chief Executive Officer and President since May 2003. From July 2009 to January 2010, he served as the Co-Chairman of the integration steering committee that provides leadership and oversight for the development and global commercialization of Cougar's lead product candidate, abiraterone acetate. Prior to Cougar, from June 1998 to April 2003 Mr. Auerbach served as a Vice President and Senior Research Analyst at Wells Fargo Securities, LLC, Research Division, where he was responsible for research coverage of small and middle capitalization biotechnology companies, with a focus on companies in the field of oncology. He had primary responsibility for technical, scientific and clinical due diligence, as well as selection of biotechnology companies followed by Wells Fargo. During 2002, he ranked second in the NASDAQ/Starmine survey of analyst performance for stock picking in biotechnology. From August 1997 to May 1998, Mr. Auerbach was a Vice President, Research Analyst at the Seidler Companies, Inc., Research Division where he was responsible for research coverage of small capitalization biotechnology companies. Prior to his work as a biotechnology analyst, he worked for Diagnostic Products Corporation, where he designed and implemented clinical trials in the field of oncology. He has been an Executive Director of Puma Biotechnology, Inc., since 2011. He served as an Independent Director of Radius Health, Inc., from May 24, 2011 to December 29, 2017. He served as a Member of Cougar Biotechnology, Inc. from May 2003 to July 2009. Mr. Auerbach received an M.S. In Biomedical Enginerring from the University of Southern California and a B.S. in Biomedical Engineering from Boston University.

Puma Biotechnology CEO Alan Auerbach At a Glance

The CEO score provides an understanding of how employees feel about the CEO’s leadership style and effectiveness at Puma Biotechnology.

Based on 9 ratings, Alan Auerbach ranks right above Celgene's CEO, Mark Alles.

Puma Biotechnology's CEO is highly regarded by Asian or Pacific Islander employees, employees with Over 10 Years experience, and Male employees. Overall, the CEO score has remained stable over the last 90 days.